US2022411756A1PendingUtilityA1
Extracellular matrices which can be used as scaffold for living cells
Assignee: UNIV FREIBURG ALBERT LUDWIGSPriority: Oct 25, 2010Filed: Jun 8, 2022Published: Dec 29, 2022
Est. expiryOct 25, 2030(~4.3 yrs left)· nominal 20-yr term from priority
C12N 2533/76C12N 5/0068C12N 5/0655C12N 5/0606C12N 5/0654C12N 2537/00C12N 2533/50C12N 5/0621C12N 2533/70C12N 5/0657C12N 2533/72C12N 5/0679C12N 2533/80C12N 5/0684C12N 2533/74C12N 5/0618C12N 5/0653C12N 5/0662C12N 5/0625C12N 5/0676C12N 5/0696C12N 5/0605C12N 5/0661
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention discloses an extracellular matrix comprising a modified polysaccharide consisting of repeating disaccharide units whereby in at least 11% of the disaccharide units one primary alcohol group is oxidized into a carboxylic acid.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A material comprising:
a modified agarose having an at least partial β-sheet structure and comprising repeat disaccharide units, wherein at least 11% of the repeat disaccharide units are carboxylic acids, and wherein the modified agarose has a shear modulus G′ in the range of from 10 Pa to 10 7 Pa.
16 . The material of claim 15 , wherein 20-90% of the repeat disaccharide units are carboxylic acids.
17 . The material of claim 15 , wherein 50-95% of the repeat disaccharide units are carboxylic acids.
18 . The material of claim 15 , wherein the modified agarose further comprises an unmodified polysaccharide.
19 . The material of claim 18 , wherein the unmodified polysaccharide is selected from the group consisting of agarose, a member of the carrageenan family, hyaluronic acid, heparin sulfate, dermatan sulfate, chondroitin sulfate, alginate, chitosan and pullulan.
20 . The material of claim 18 , wherein the unmodified polysaccharide comprises agarose.
21 . The material of claim 18 , wherein the modified agarose is obtained from agarose exhibiting an alpha-helix structure.
22 . The material of claim 18 , further comprising a peptide sequence covalently coupled to the carboxylic acids.
23 . The material of claim 18 , further comprising a nucleic acid sequence covalently coupled to the carboxylic acids.
24 . The material of claim 15 , wherein the material has a shear modulus G′ in the range of from 1 Pa to 100 kPa.
25 . The material of claim 15 , wherein the material has a shear modulus G′ in the range of from 1 Pa to 50 kPa.
26 . The material of claim 15 , wherein the material has a shear modulus G′ in the range of from 10 Pa to 10 kPa.
27 . The material of claim 15 , wherein the material is an implant.
28 . The material of claim 15 , wherein the material is a regenerative implant.
29 . The material of claim 30 , wherein the regenerative implant is an artificial skin.
30 . The material of claim 15 , wherein the material is injectable into a subject.
31 . The material of claim 15 , wherein the material further comprises living cells.
32 . The material of claim 15 , wherein the material is implanted as skin in a subject.Join the waitlist — get patent alerts
Track US2022411756A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.